![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA APPROVES AUROBINDO'S PEDIATRIC POWDER FOR HIV TREATMENT
FDA APPROVES AUROBINDO'S PEDIATRIC POWDER FOR HIV TREATMENT
The US FDA has granted India-based Aurobindo a tentative approval for its Didanosine Oral Suspension (Pediatric Powder) 10 mg/ml. It is indicated for use in pediatric patients with HIV. BioSpectrum (http://www.biospectrumasia.com/content/111006IND1857.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct